We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
International Flavors (IFF) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
Read MoreHide Full Article
Wall Street analysts expect International Flavors (IFF - Free Report) to post quarterly earnings of $1.12 per share in its upcoming report, which indicates a year-over-year decline of 0.9%. Revenues are expected to be $2.83 billion, down 2.2% from the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 1.6% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some International Flavors metrics that Wall Street analysts commonly model and monitor.
It is projected by analysts that the 'Net Sales- Nourish' will reach $1.45 billion. The estimate indicates a change of -2.8% from the prior-year quarter.
The consensus estimate for 'Net sales- Scent' stands at $609.74 million. The estimate indicates a change of -5.5% from the prior-year quarter.
Analysts' assessment points toward 'Net Sales- Pharma Solutions' reaching $233.97 million. The estimate indicates a year-over-year change of +3.1%.
Analysts expect 'Net Sales- Health & Biosciences' to come in at $532.05 million. The estimate indicates a change of +0.2% from the prior-year quarter.
Analysts forecast 'Adjusted Operating EBITDA- Nourish' to reach $216.88 million. Compared to the current estimate, the company reported $216 million in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Adjusted Operating EBITDA- Pharma Solutions' should arrive at $45.50 million. The estimate compares to the year-ago value of $46 million.
According to the collective judgment of analysts, 'Adjusted Operating EBITDA- Scent' should come in at $140.59 million. The estimate compares to the year-ago value of $157 million.
The consensus among analysts is that 'Adjusted Operating EBITDA- Health & Biosciences' will reach $159.94 million. Compared to the current estimate, the company reported $159 million in the same quarter of the previous year.
Over the past month, International Flavors shares have recorded returns of -0.2% versus the Zacks S&P 500 composite's -0.7% change. Based on its Zacks Rank #3 (Hold), IFF will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
International Flavors (IFF) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
Wall Street analysts expect International Flavors (IFF - Free Report) to post quarterly earnings of $1.12 per share in its upcoming report, which indicates a year-over-year decline of 0.9%. Revenues are expected to be $2.83 billion, down 2.2% from the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 1.6% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
That said, let's delve into the average estimates of some International Flavors metrics that Wall Street analysts commonly model and monitor.
It is projected by analysts that the 'Net Sales- Nourish' will reach $1.45 billion. The estimate indicates a change of -2.8% from the prior-year quarter.
The consensus estimate for 'Net sales- Scent' stands at $609.74 million. The estimate indicates a change of -5.5% from the prior-year quarter.
Analysts' assessment points toward 'Net Sales- Pharma Solutions' reaching $233.97 million. The estimate indicates a year-over-year change of +3.1%.
Analysts expect 'Net Sales- Health & Biosciences' to come in at $532.05 million. The estimate indicates a change of +0.2% from the prior-year quarter.
Analysts forecast 'Adjusted Operating EBITDA- Nourish' to reach $216.88 million. Compared to the current estimate, the company reported $216 million in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Adjusted Operating EBITDA- Pharma Solutions' should arrive at $45.50 million. The estimate compares to the year-ago value of $46 million.
According to the collective judgment of analysts, 'Adjusted Operating EBITDA- Scent' should come in at $140.59 million. The estimate compares to the year-ago value of $157 million.
The consensus among analysts is that 'Adjusted Operating EBITDA- Health & Biosciences' will reach $159.94 million. Compared to the current estimate, the company reported $159 million in the same quarter of the previous year.
View all Key Company Metrics for International Flavors here>>>
Over the past month, International Flavors shares have recorded returns of -0.2% versus the Zacks S&P 500 composite's -0.7% change. Based on its Zacks Rank #3 (Hold), IFF will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>